Obatoclax for Systemic Mastocytosis

计划入组 3 人 · 首次发布于 2009 年 6 月 11 日

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

首次发布于 2025 年 4 月 8 日

Midostaurin in Indolent Systemic Mastocytosis

计划入组 20 人 · 首次发布于 2013 年 8 月 9 日

Systemic Mastocytosis(Alys)

Midostaurin(Rydapt)

C₃₅H₃₀N₄O₄

Imatinib(Gleevec, Glivec, Imatinib Teva, Imatinib Accord, Imatinib Koanaa, Imatinib medac)

C₂₉H₃₁N₇O · Rx

Cadrenal Therapeutics

United States

Edesa Biotech

Canada

Entero Therapeutics

NICE Recommends Blueprint Medicines' Ayvakyt for Advanced Systemic Mastocytosis on NHS

Bezuclastinib Shows Strong Symptom and Biomarker Improvement in Non-Advanced Systemic Mastocytosis

Cogent Biosciences Raises $475.3 Million to Advance Bezuclastinib for Systemic Mastocytosis